Outcomes of a co-located approach for metabolic health care for people with schizophrenia
File version
Author(s)
Yen, Wesley
Thuzar, Moe
Russell, Anthony
Warren, Nicola
Kisely, Steve
Kar Ray, Manaan
Motamarri, Balaji
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
OBJECTIVE: Metabolic syndrome is highly prevalent among people with schizophrenia. This study aims to assess the impact on metabolic and attendance outcomes of a co-located, dedicated, endocrinologist-led metabolic clinic in a stand-alone public community mental health service. METHODS: Demographic and metabolic data on the first 48 consecutive referrals over a 12-month period were retrospectively collected and analysed. Attendance rates at the co-located clinic were compared to the general hospital obesity and diabetes clinics. RESULTS: Clinic attendees had significant reductions in triglycerides and total cholesterol, but not mean weight, BMI, waist circumference, blood pressure or HbA1c. Attendance rates were significantly higher in the co-located clinic compared to the general hospital obesity and diabetes clinics for both initial consult (80.0% vs 51.2%, p < 0.001) and review appointment (64.3% vs 47.6%, p < 0.001). CONCLUSION: The co-location of a specialist metabolic clinic within a mental health service resulted in enhanced engagement and improvement of metabolic health in people with schizophrenia.
Journal Title
Australasian Psychiatry
Conference Title
Book Title
Edition
Volume
30
Issue
4
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Psychiatry (incl. psychotherapy)
co-location
dyslipidaemia
mental health
metabolic syndrome
schizophrenia
Persistent link to this record
Citation
Siskind, D; Yen, W; Thuzar, M; Russell, A; Warren, N; Kisely, S; Kar Ray, M; Motamarri, B, Outcomes of a co-located approach for metabolic health care for people with schizophrenia, Australasian Psychiatry, 2022, 30 (4), pp. 518-522